Financhill
Back

Protagonist Therapeutics Stock Predictions

Protagonist Therapeutics Stock Forecast

  • Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 39.4% based on the past 8 years of stock performance.
  • Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
  • Is Protagonist Therapeutics Stock Undervalued?
    The current Protagonist Therapeutics [PTGX] share price is $41.49. The Score for PTGX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will Protagonist Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 39.4% based on the past 8 years of stock performance.

Protagonist Therapeutics Stock Rating

Sell
48
Protagonist Therapeutics (PTGX) is a Sell

Is Protagonist Therapeutics overpriced?

  • Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%

Protagonist Therapeutics Stock Price History

Is PTGX stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PTGX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com

52-Week Data

52-Week High:
48.89
52-Week Low:
21.43

Prediction Charts

Market Cap:
2.5B
Price in USD:
41.49
Volume:
2.3M
Beta:
2.06

Technical Analysis

SMA50:
43.96
SMA100:
43.23
SMA200:
37.02
52-Wk Change:
99.95%

Stock Predictions

  • Is Protagonist Therapeutics stock public?
    Yes, Protagonist Therapeutics is a publicly traded company.
  • What is the Protagonist Therapeutics stock quote today?
    The Protagonist Therapeutics stock price is 41.49 USD today.
  • How to buy Protagonist Therapeutics stock online?
    You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 43.06 41.25 43.49 41.00
Dec-4 41.71 40.58 42.18 40.00
Dec-5 40.74 41.68 43.05 40.70
Dec-6 41.96 42.06 42.77 41.31
Dec-9 42.03 40.50 42.58 40.30
Dec-10 40.70 41.60 42.38 40.54
Dec-11 41.68 41.00 42.20 40.95
Dec-12 41.69 40.38 42.08 39.85
Dec-13 40.35 41.08 41.46 39.60
Dec-16 41.19 41.46 41.97 41.05
Dec-17 40.99 40.69 41.13 39.63
Dec-18 40.71 39.04 41.18 38.62
Dec-19 38.94 39.54 40.00 38.61
Dec-20 39.01 41.49 41.68 38.91

Protagonist Therapeutics Earnings

Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Protagonist Therapeutics Forecast Revenue Growth

Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.57 per share, and a decrease next year of $3.76 per share.

* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.